<DOC>
	<DOCNO>NCT01909401</DOCNO>
	<brief_summary>Currently , treatment standard use anti-HCV ( hepatitic C virus ) medication prepare liver transplant . The purpose study determine whether individual require liver transplantation Hepatitis C , genotype I , undergo liver transplantation may successfully get rid virus transplant take three medicine , peginterferon , ribavirin , boceprevir , time liver transplant surgery . If successful , Hepatitis C virus re-infect new liver receive require therapy Hepatitis C liver transplantation . This study involve use peginterferon alfa-2b , ribavirin , boceprevir , approve treatment genotype I Hepatitis C. Hypothesis : The addition boceprevir peginterferon alfa-2b ribavirin patient Hepatitis C genotype 1 without hepatocellular carcinoma undergo orthotopic liver transplantation lead rapid HCV RNA clearance genotype I infect individual . Transplantation anhepatic boceprevir prevent reinfection new transplant graft prevent graft infection posttransplantation .</brief_summary>
	<brief_title>Pilot Study With Peginterferon , Ribavirin , Boceprevir Prior Transplantation Clear Virus Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation</brief_title>
	<detailed_description>Subject Patient Inclusion Criteria : Men woman age 18 70 inclusive , patient genotype I Hepatitis C list orthotopic liver transplantation ( OLT ) enrol . Those hepatocellular carcinoma without treatment hepatoma may also include . The MELD score enrollment cap 16 . Patients must medically control ascites moderate poorly control ascites exclude . Treatment Plan : Fifteen patient chronic genotype I Hepatitis C enrol . All patient begin peginterferon ribavirin 4 week addition boceprevir Week 4 orthotopic liver transplantation . The dose interferon peginterferon 1.0 mcg/kg weight-based ribavirin ( 600-1200 mg ) boceprevir 800 mg TID ( three time per day ) OLT . All patient list orthotopic liver transplantation . HCV RNA measure monthly . When call transplant , take last dose ribavirin prior go operate room . Patients undergo orthotopic liver transplantation standard protocol Indiana University . They receive Dobhoff boceprevir 800 tid 3 dos post transplantation . Virologic failure HCV RNA &gt; 100 I.U . Week 12 .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Men woman age 1870 Patients must genotype I HCVinfected individual cirrhosis undergo orthotopic liver transplantation . Those hepatocellular carcinoma without treatment hepatoma may also include . The MELD score enrollment cap 16 . Patients must medically control ascites moderate poorly control ascites exclude . Inclusion Laboratory Values ALT ( alanine aminotransferase ) &lt; 250 IU/L , AST ( Aspartate aminotransferase ) &lt; 250 IU/L , total bilirubin &lt; 3 mg/dl , creatinine clearance &gt; 45 ml MDRD ( Modification Diet Renal Disease ) , albumin &gt; 2.8 g/dl , hemoglobin &gt; 11 , white count &gt; 2.0 X103 , absolute neutrophil count 1.5 X103 , platelet count &gt; 50,000 . Women childbearing potential male patient sexual female partner childbearing potential use two acceptable method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Liver Transplantation</keyword>
</DOC>